Physician profile
Eugene Elia
NPI 1750464012
$1,705.52
in general payments reported to CMS, 2019-2025
14 companies · $249 in 2025
The $249 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $928 · 2020: $38.62 · 2021: $96.75 · 2022: $29.87 · 2023: $250 · 2024: $113 · 2025: $249.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $612.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $612.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $750.39 | 2019 | |
| Depuy Synthes Sales INC. | $295.49 | 2019-2024 | Monovisc, Orthovisc |
| Zimmer Biomet Holdings, INC. | $235.41 | 2023-2025 | Gel-One Cross-Linked Hyaluronate |
| Stryker Corporation | $178.06 | 2025 | Mako, Triathlon |
| Medtronic, INC. | $50.11 | 2023 | Biosyn |
| Heraeus Medical, LLC. | $40.07 | 2019-2023 | Palacos |
| Kowa Pharmaceuticals America, INC. | $29.87 | 2022 | |
| Ferring Pharmaceuticals INC. | $22.14 | 2025 | Euflexxa |
| Orthogenrx INC. | $21.13 | 2020 | |
| Ermi LLC | $19.65 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $17.46 | 2023 | Exparel, Iovera, Zilretta |
| Avanos Medical | $16.88 | 2021 | |
| Pacira Therapeutics, INC. | $16.19 | 2019 | |
| Heron Therapeutics, INC. | $12.67 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eugene Elia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.